通过STAT1介导的LIN28A表观遗传调节,通过let-7-RALB轴控制iPSC衍生的血小板生产
Kazuya Hashimoto1,2, Si Jing Chen3, Kosuke Fujio1,4
1Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Blood advances
|June 17, 2025
概括
研究人员确定STAT1是干细胞血小板生产的关键调节者. 抑制STAT1可以促进血小板的产生,这为制造用于输血的血液制品提供了新的策略.
科学领域:
- 干细胞生物学 干细胞生物学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 从诱导的多能干细胞 (iPSCs) 产生活体血小板 (PLT) 提供了一个对依赖于捐赠者的输血的替代方案.
- 来自iPSC的不朽化巨核细胞原生细胞系 (imMKCLs) 允许大规模的PLT制造,但面临着细胞异质性和衰老的挑战.
- 鉴定出一种类似RAS的原型瘤基因B作为imMKCL免疫性质和PLT生产力的调节者,是let-7a-5p微RNA的下游.
研究的目的:
- 在iPSC衍生的巨核细胞原生细胞系的背景下识别let-7a-5p微RNA的上游调节者.
- 研究Lin-28同类A (LIN28A) 的作用及其在PLT生产中的调控机制.
- 探索影响LIN28A表达和随后的PLT生成的转录调节剂.
主要方法:
- 在不同的imMKCL群体中分析LIN28A位点的DNA甲基化模式.
- 过度表达LIN28A以评估其对免疫信号和PLT产生的影响.
- 动因丰富分析和小干扰RNA (siRNA) 介导的淘汰,以确定LIN28A.的转录调节者.
- 使用fludarabine和flavopiridol,抑制STAT1酸化.
主要成果:
- 在imMKCLs中的LIN28A表达是由DNA甲基化调节的,在let-7high和let-7low细胞之间观察到不同的模式.
- 过度表达LIN28A可提高免疫相关信号的调节,降低PLT的产生.
- 确定STAT1是LIN28A的上游调节者;STAT1的淘汰减少了免疫基因表达,增加了PLT的产生.
- 抑制STAT1酸化增强了PLT生成,这表明它在细胞循环停止和细胞亡之外发挥了新的作用.
结论:
- 通过DNA甲基化调节的LIN28A,在imMKCLs中调节免疫信号和PLT产生中发挥作用.
- STAT1作为LIN28A的关键上游调节器,影响免疫反应和PLT生成.
- 向STAT1酸化提供了一个有前途的策略,以提高输血治疗的ex vivo PLT制造.
更多相关视频
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
12.4K
10:25Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
9.6K
相关概念视频
01:21Lineage Commitment
3.2K
Commitment is the process whereby stem cells:
3.2K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
01:18Structure and Function of Platelets
1.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
01:20The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
01:21Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K